Millennium Management »

Rapt Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 39k 25.79
2025-06-30 $179k 22k 8.00

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics